Edition:
United States

Marina Biotech Inc (MRNA.PK)

MRNA.PK on OTC Markets Group

1.85USD
17 Nov 2017
Change (% chg)

$0.15 (+8.82%)
Prev Close
$1.70
Open
$1.49
Day's High
$1.85
Day's Low
$1.49
Volume
11,454
Avg. Vol
3,881
52-wk High
$5.00
52-wk Low
$0.75

Chart for

About

Marina Biotech, Inc. is a biotechnology company focused on the discovery, development and commercialization of nucleic acid-based therapies to treat orphan diseases. The Company's pipeline includes CEQ508, a product in clinical development for the treatment of Familial Adenomatous Polyposis (FAP), and preclinical programs for... (more)
No analyst recommendations are available for .

Overall

Beta: 1.14
Market Cap(Mil.): $19.46
Shares Outstanding(Mil.): 10.52
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 197.02 15.79
EPS (TTM): -- -- --
ROI: -- -10.12 12.01
ROE: -- -37.71 15.91

BRIEF-Marina Biotech appoints Amit Shah as chief financial officer

* Marina Biotech appoints Amit Shah as chief financial officer Source text for Eikon: Further company coverage:

Oct 05 2017

BRIEF-Marina Biotech announces appointment of Dr. Vuong Trieu as executive chairman

* Marina biotech announces the appointment of dr. Vuong trieu as executive chairman Source text for Eikon: Further company coverage:

Jul 05 2017

Earnings vs. Estimates